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ABSTRACT: Purified plasma membranes from the yeast Saccharomyces cerevisiae bind about 1.2 pmol of 
cAMP/mg of protein with high affinity (Kd = 6 nM). By using photoaffinity labeling with 8-N3-[32P]cAMP, 
we have identified in plasma membrane vesicles a CAMP-binding protein (M, = 54 000) that is present also 
in bcyl disruption mutants, lacking the cytoplasmic R subunit of protein kinase A (PKA). This argues 
that it is genetically unrelated to PKA. Neither high salt, nor alkaline carbonate, nor CAMP extract the 
protein from the membrane, suggesting that it is not peripherally bound. The observation that (glyco- 
sy1)phosphatidylinositol-specific phospholipases (or nitrous acid) release the amphiphilic protein from the 
membrane, thereby converting it to a hydrophilic form, indicates anchorage by a glycolipidic membrane 
anchor. Treatment with N-glycanase reduces the M, to 44000-46000 indicative of a modification by N-linked 
carbohydrate side chain(s). In addition to the action of a phospholipase, the efficient release from the 
membrane requires the removal of the carbohydrate side chain(s) or the presence of high salt or methyl 
a-mannopyranoside, suggesting complex interactions with the membrane involving not only the glycolipidic 
anchor but also the glycan side chain(s). Topological studies show that the protein is exposed to the 
periplasmic space, raising intriguing questions for the function of this protein. 
I n  the yeast Saccharomyces cerevisiae, CAMP‘ is known to 
influence a number of cellular processes and to link them to 
the nutritional situation of the cell. Among them are storage 
carbohydrate metabolism (Pall, 1981; Thomer, 1982), cell size 
regulation and cell cycle progression (Matsumoto et al., 1985; 
Baroni et al., 1989), sporulation (Matsumoto et al., 1983a,b), 
and transcription (Merino et al., 1989). Control of these 
functions is thought to be achieved through the activation of 
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the well-characterized cytoplasmic CAMP-dependent protein 
kinases (Beebe & Corbin, 1986) in response to the modulation 
I Abbreviations: CAMP, adenosine 3’,5’-cyclic monophosphate; C (R) 
subunit, catalytic (regulatory) subunit; DTT, dithiothreitol; EDTA, 
ethylendiaminetetraacetic acid; EGTA, ethylene glycol bis(&aminoethyl 
ether)-N,N,N’,N’-tetraacetic acid; GPI, glycosylphosphatidylinositol; 
HEPES, N-( 2-hydroxyethyl)piperazine-N’-2-ethanesulfonic acid; IBMX, 
3-isobutyl-1-methylxanthine; MES, 2-(N-morpholino)-ethanesulfonic 
acid; a-MMP, methyl a-mannopyranoside; MOPS, 3-(N-morpholino)- 
propanesulfonic acid; N-glycanase, peptide N-glycohydrolase F; PEG, 
poly(ethy1ene glycol); (G)PI-PLC (D), (g1ycosyl)phosphatidylinositol- 
specific phospholipase C (D); PKA, CAMP-dependent protein kinase; 
PMSF, phenylmethanesulfonyl fluoride; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis; TCA, trichloroacetic acid; 
Tris, tris(hydroxymethy1)aminomethane; TX-114, Triton X-114, poly- 
(ethylene glycol) mono(octy1 phenyl ether). 
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of the intracellular cAMP concentration (Matsumoto et al., 
1982a; Uno et al., 1982). CAMP-dependent protein kinases 
(PKA's) are heterotetrameric in yeast and in most other or- 
ganisms, built up from two regulatory, CAMP-binding (R) and 
two catalytic (C) subunits (Edelman et al., 1987). The binding 
of cAMP to R effects the dissociation of the complex, resulting 
in the release of two active C subunits. This type of protein 
kinase A usually occurs in the cytoplasm but has also been 
observed associated with the cytoplasmic faces of a variety of 
intracellular membranes (Nigam & Blobel, 1989; Nigg et a]., 
1985a,b) including plasma membranes (Behrens & Mazon, 
1988). Since the constituent R and C subunits lack obvious 
transmembrane domains, the binding to the various mem- 
branes appears to be mediated by protein-protein interactions. 
Alternatively, posttranslational modifications, e.g., acylation 
with long chain fatty acids, of proteins have been attributed 
a functional role in their association with membranes (Olson 
& Spitz, 1986; Rhee & Hunter, 1987). 
A new type of CAMP-dependent protein kinase has been 
found recently in mitochondria embedded in the organelle's 
inner membrane (Rodel et al., 1985; Muller & Bandlow, 
1987). Its membrane association is due neither to ionic pro- 
tein-protein interactions nor to a proteinaceous transmembrane 
domain but is due to anchorage of the CAMP-binding protein 
by a lipid structure containing phosphatidylinositol lacking 
carbohydrate (Muller & Bandlow, 1989b). 
Here we describe a similar CAMP-binding protein in plasma 
membranes from yeast. It shares the property with the mi- 
tochondrial counterpart that it is bound to the membrane by 
a lipid-containing structure that can be cleaved by GPI-specific 
phospholipases. It differs from the mitochondrial isoprotein 
in molecular weight, being larger mainly due to N- 
glycosylation. We present also strong evidence that this 
CAMP-binding protein is different from the R subunit of the 
cytoplasmic PKA and is oriented toward the extracellular 
space. 
MATERIALS AND METHODS 
Materials were obtained as follows: N-[3H]acetyl conca- 
navalin A (45 Ci/mmol) from Amersham-Buchler, Braun- 
schweig; 8-N3-[32P]cAMP (20 Ci/mmol) from ICN, Es- 
chwege; concanavalin A-Sepharose and Percoll from Phar- 
macia, Freiburg; PLA, (Crotalus atrox) from Calbiochem, 
La Jolla, CA; PI-PLC (Bacillus cereus) and N-glycanase 
(Flavobacterium menigosepticum) from Boehringer, Mann- 
heim. GPI-PLD from rabbit serum was a donation from W. 
Gutensohn, Munchen; GPI-PLC from Trypanosoma brucei 
was the gift of P. Overath, Tubingen. Mixed ester cellulosic 
filters were purchased from Millipore, Eschborn; CAMP, 
a-MMP, and PEG 4000 were from Sigma, Deisenhofen, all 
other chemicals were obtained as described (Muller & 
Bandlow, 1989a). 
Yeast Strains, Cell Growth, and Subcellular Fractionation. 
Cells from the haploid protease-deficient strain ABYSl MAT 
pral-1 prbl-1 prcl-1 cpsl-3 ade lacking the vacuolar pro- 
teinases A and B and carboxypeptidases Y and S (Achstetter 
et al., 1984) and from the bcyl disruption mutant EG273-5A 
MATa leu2 ura3 his4 ade2-1 bcyl::HIS3 (Cannon & Tatc- 
hell, 1987) were grown at 30 "C to log phase in lactate me- 
dium as described (Muller & Bandlow, 1989a). Cellular 
subfractions were isolated from spheroplasts (Rodel et al., 
1985). All subsequent experimental steps were performed in 
the presence of a cocktail of protease inhibitors (Muller & 
Bandlow, 1989a). The cell lysate was centrifuged (lOOOg, 3 
min, 4 "C), the pellet was washed with SEM buffer (0.25 M 
sucrose, 0.5 mM EDTA, 20 mM MOPS/KOH, pH 7.4) and 
Muller and Bandlow 
recentrifuged two times, and the combined supernatants were 
adjusted to 28% Percoll in SEM buffer (0.5 mg of protein@) 
and centrifuged (18OOOg, 15 min, 4 "C, fixed angle rotor). 
The cytoplasmic supernatant on top of the gradient was 
cleared by centrifugation (300000g, 60 min, 4 "C) and pre- 
cipitated by 15% PEG 6000 (48000g, 30 min), washed, and 
finally dissolved in 25 mM Tris-HC1 (pH 7.0), 1 mM EDTA 
at 4 mg/mL. The band just below the top of the gradient 
(plasma membranes, 3 mL) was diluted with 5 volumes of 
SEM buffer and spun down (48000g, 30 min, 4 "C). The 
pellet was resuspended in MOPS buffer at 5 mg/mL and 
incubated in portions of 1 mg of protein with 55  pCi of N- 
[3H]acetyl concanavalin A in a total volume of 500 pL of 
MOPS buffer (20 mM MOPS/KOH, pH 7.4, 0.5 mM 
EDTA, 50 mM KCl, 5 mM CaC12, 200 pg of BSA) under 
mild ultrasonic treatment in a water bath sonifier for 60 min 
at 4 "C. The suspension was layered on top of a continuous 
sucrose gradient (1 5 2 8 %  sucrose in MOPS buffer) and 
centrifuged (25 000 rpm, 90 min, 4 "C, Beckman SW27 rotor), 
and the gradients were fractionated from the bottom (0.6-mL 
portions), and aliquots were counted for radioactivity. Peak 
fractions (23% sucrose) were diluted 3-fold with MOPS buffer 
containing 50 mM concanavalin A and 250 mM KCI and spun 
down (200000g, 60 min, 4 "C, Beckman TL-100, fixed angle 
rotor). The pellet was washed and recentrifuged two times 
with SEM buffer containing 250 mM KCI and once with SEM 
buffer lacking KCI and finally suspended in SEM buffer at 
2.5 mg of protein/mL. 
Microsomes were recovered from the middle band of the 
above Percoll gradient (1.5 mL), diluted 3-fold with MOPS 
buffer containing 150 mM KCl, and centrifuged (1 00 OOO rpm, 
4 OC, 60 min, Beckman TL-100, fixed angle rotor). The pellet 
was resuspended in the same buffer containing 0.25 M sucrose 
at 0.5 mg/mL, layered on top of a 0.5 M sucrose cushion in 
the same buffer, and centrifuged (40000 rpm, 90 min, 4 "C, 
Beckman TL-100, swing out rotor). The final pellet was 
resuspended in 0.1 M sucrose/20 mM MOPS (pH 7.2)/0.5 
mM EDTA (1.5 mg/mL). 
Mitochondria were prepared from the lower band in the 
lower one-third of the above Percoll gradient (1.5 mL), diluted 
with 10 volumes of SEM buffer, and centrifuged (20000g, 30 
min, 4 "C). The pellet was suspended in SEM buffer ( 5  
mg/mL), layered on top of a 2.5-mL (per milligram of protein) 
cushion of 28% Percoll in SEM buffer, and further centrifuged 
and processed as described previously (Muller & Bandlow, 
1989a). Aliquots of subcellular fractions were frozen in liquid 
nitrogen and stored at -70 "C. 
Separation of Inside Out and Outside Out Plasma Mem- 
brane Vesicles. Diluted (125 pg of protein/mL, with 20 
volumes of 20 mM MOPS, pH 7.2/0.5 mM EDTA) and 
sonicated (10 pulses of 15 s each, Branson waterbath sonifier 
at maximum intensity) plasma membrane vesicles were spun 
down (200000g, 60 min, 4 "C) and resuspended in SEM buffer 
(1 mg/mL) containing 1 pg/mL bacitracin, 20 pg/mL PMSF, 
2 mM MgCl,, 5 mM CaC12, 75 mM KCl, and 10% glycerol. 
The suspension was mixed batchwise with 5 mL of concana- 
valin A-Sepharose (1 5 mg/mL) in the same buffer (bacitracin 
omitted) and left on ice for 30 min under stirring to allow 
agglutination. The suspension was then filled into a column. 
Inside out vesicles were washed from the column with 2 
volumes of the same buffer and centrifuged through a cushion 
of 5 mL of 0.5 M sucrose in 25 mM MOPS/KOH (pH 7.4)/1 
mM EDTA/75 mM KC1/20 pg/mL PMSF (lOOOOOg, 60 
min, 4 OC, Beckman TL-100, swing out rotor). The pellet 
(inside out vesicles) was washed twice with SEM buffer and 
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suspended in the same buffer at 2 mg/mL. Outside out 
vesicles were subsequently eluted with 5 volumes of 0.1 M 
a-MMP in 50 mM MOPS/KOH (pH 7.4)/0.2 mM EDTA 
containing 250 mM KCI, 10% glycerol, 1 pg/mL bacitracin, 
and 20 pg/mL PMSF. Protein-containing fractions (0.5 mL) 
were pooled and centrifuged as described above. 
Phospholipase Treatments. A total of 75 pg of mitochon- 
drial or plasma membranes or 150 pg of spheroplasts, pho- 
toaffinity labeled with 8-N3-[32P]~AMP (approximately 
100000 cpm), was pelleted (looOOOg, 30 min, or 5000g, 5 min, 
respectively) and washed in the respective incubation buffers. 
For PLA, treatment, the membranes were suspended in 500 
pL of 0.5 M Tris-HC1 (pH 7.5)/0.25 M sucrose/l5 mM 
CaCl, containing 0.5% TX-100. A total of 50 pL of PLA2 
solution (1  5 mg/mL) was added and the mixture incubated 
for 1 h at 37 "C. For PI-PLC (B.  cereus) treatment, the 
membranes were resuspended in 500 pL of HEPES/NaOH 
buffer (pH 7.4)/0.25 M sucrose. For solubilization 0.1% (w/v) 
sodium deoxycholate was added and the supernatant of a 
centrifugation (150000g, 60 min, 4 "C) was used for the 
digestion. A total of 25 pL of a PI-PLC stock solution (about 
2.5 p g  of enzyme) was added, and the mixtures were incubated 
for 1 h at 37 "C. For treatment with GPI-PLC ( T .  brucei) 
the membranes were suspended in 500 pL of 10 mM Tris-HC1 
(pH 8.0)/0.25 M sucrose/l50 mM NaCl. A total of 10 pL 
of trypanosoma1 PLC (0.5 unit) was added, and the mixture 
was incubated for 30 min at 30 "C. For GPI-PLD treatment 
the membranes were suspended in 500 pL of 20 mM potassium 
phosphate (pH 5.6)/0.25 M sucrose/75 mM CaCI,, 50 pg of 
GPI-PLD was added, and the mixture incubated for 90 min 
at 37 "C. The incubations were terminated by the addition 
of 2 mM EGTA/l mM EDTA and separation into soluble 
and membrane-associated proteins by centrifugation (1 5oooOg, 
60 min, 4 "C) or into hydrophilic and amphiphilic proteins 
by TX- 1 14 partitioning. 
N-Glycanase Treatment. A total of 100000 cpm of 8- 
N3- [32P] cAMP photoaffinity-labeled mitochondrial or plasma 
membranes was dissolved in 0.1 M sodium phosphate buffer 
(pH 8.6)/0.25 M sucrose/lO mM l,lO-phenanthroIine/5 mM 
DTT/O.l% SDS. The supernatant of a centrifugation 
(1 5oooOg, 30 min, 4 "C) was then incubated with N-glycanase 
(with 2.5 units for 18 h at 37 "C) in the presence of 0.01% 
SDS. The digestions were terminated by the addition of 
acetone/0.07 M HCl followed by centrifugation at 12OOOg for 
10 min. Precipitates were washed successively with acetone, 
0.07 M HCI, and ether and dried. The protein was dissolved 
in 25 pL of 50 mM Tris-HC1 (pH 6.8), containing 1% SDS, 
5 mM EDTA, and 1 mM b-mercaptoethanol, boiled for 5 min, 
and analyzed by SDS-PAGE. 
Photoaffinity-labeled sealed (1.5 M sorbitol) or deter- 
gent-solubilized (0.5% MEGA 10) yeast spheroplasts or 
homogenate was incubated at 0.5 mg/mL in 0.1 M phosphate 
buffer (pH 8.6)/5 mM DTT/lO mM l,l0-phenanthroline with 
25 units/mg N-glycanase for 3 h at 30 "C, and the digestions 
were terminated by the addition of trypsin (40 pg/mL, 30 min, 
4 "C) and subsequent centrifugation of the intact spheroplasts 
through a 0.5 M sucrose cushion (5000g, 10 min) or precip- 
itation of the solubilized spheroplasts and homogenate (8% 
PEG 4000, 30 min, 4 "C, followed by centrifugation 1OOOOOg, 
15 min), respectively, in the presence of a 4-fold molar excess 
of bovine trypsin inhibitor and 100 pM PMSF. 
Nitrous Acid Deamination. A total of 150 pg of pho- 
toaffinity-labeled plasma membrane vesicles (approximately 
50000 cpm) was incubated at 25 "C in 0.5 mL of 0.25 M 
sodium acetate (pH 3 .3 ,  in the presence of freshly dissolved 
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0.2 M NaN0,. For subsequent TX-114 partitioning the re- 
action was terminated by precipitation with 10% TCA. 
Precipitates were washed successively with ice-cold 5% TCA, 
acetone, and 70% ethanol, dried, dissolved in 75 pL of 20 mM 
Tris-HC1 (pH 7.2)/0.5 mM EDTA/5 mM DTT/20% gly- 
cerol/0.5% MEGA 10, and analyzed by TX- 1 14 partitioning. 
For subsequent analysis by centrifugation the membranes were 
spun through a cushion of 0.5 M sucrose (in the same buffer 
as described above, omitting the detergent, 150000g, 30 min, 
4 "C). 
Photoaffinity Labeling. Labeling experiments were per- 
formed by incubating 400 pL of plasma membranes or 
spheroplasts (200 pg) in 0.25 M sucrose (plasma membranes) 
or 1.25 M sorbitol (spheroplasts) and 25 mM MES (pH 
6.2)/50 mM KCl/10 mM MgC1,/2 mM MnC12/1 mM 
IBMX/O.5 mM @-mercaptoethanol/OS mM EDTA/100 pM 
5'-AMP/protease inhibitors (see above) with 50 pCi of 8- 
N3-[32P]cAMP in the wells of a ceramical serology plate at 
4 "C for 30 min in the presence or absence of 100 pM non- 
radioactive CAMP. Samples were then irradiated at 254 nm 
with a UV hand lamp for 5 min at a distance of 2 cm. The 
reaction was terminated by the addition of 100 pM CAMP. 
Membranes or spheroplasts were spun through cushions of 0.5 
M sucrose in the same buffer (150000g, 30 min, or 5000g, 10 
min, respectively). For subsequent fractionation, labeled 
spheroplasts were diluted with 50 mg of unlabeled spheroplasts. 
Enzyme assays were carried out according to published 
procedures in the presence of 0.25% octyl glucoside and 75 
mM KCl: adenylate cyclase (Salomon et al., 1974), citrate 
synthase (Srere, 1965), NADH:cytochrome c oxidoreductase 
(Dallner et al., 1966), succinate:cytochrome c oxidoreductase 
(Lang et al., 1977), and hexokinase (Gruber et al., 1966). 
Miscellaneous Procedures. The CAMP-binding assay (using 
25 nCi of 13H]cAMP per incubation and a filtration techni- 
que), photoaffinity labeling of mitochondria with 8-N3- 
[32P]~AMP, hydrophilic/hydrophobic partitioning with TX- 
1 14, SDS-PAGE, fluorography, and protein determination 
were carried out as reported in previous papers (Muller & 
Bandlow, 1989a-c). Alkaline extraction, using 250 pg of 
photoaffinity-labeled plasma membranes in 500 pL of 0.2 M 
sodium carbonate (pH 11.5) was performed as described by 
Mostov et al. (1981). 
RESULTS 
Plasma Membranes Bind cAMP Speci3cally. Yeast plasma 
membranes bind a considerable fraction of the total cAMP 
that associates specifically with subcellular components. This 
is evident particularly when a fractionation scheme is applied 
(see Materials and Methods) that allows the recovery of more 
than 50% of the plasma membranes present in the cell hom- 
ogenate (based on the yield of adenylate cyclase as a specific 
marker). In this procedure, designed to minimize losses during 
the preparation, a homogenate obtained from osmotically lysed 
spheroplasts was directly subjected to Percoll density gradient 
centrifugation. Plasma membranes, radiolabeled with con- 
canavalin A as a specific marker and purified by two successive 
gradient centrifugations, were strongly enriched in adenylate 
cyclase activity and contained only minor contaminations from 
other cellular compartments (Figure 1). Similarly, the purity 
of the mitochondrial fraction was verified by the relative en- 
richments and recoveries of the specific markers, succinate: 
cytochrome c oxidoreductase and citrate synthase, with the 
simultaneous deprivation of microsomal, cytosolic, and plasma 
membrane markers. Most of the CAMP-binding activity was 
recovered in the mitochondrial fraction (about 4-fold enrich- 
ment). But CAMP-binding to plasma membranes, which 
10184 Biochemistry, Vol. 30, No. 42, 1991 Miiller and Bandlow 
* +  I ' 1  I 
2 
0 
- 1.6 
I I 
0.76 0 
0 60 1m 
% OF TOTAL CEUULARPROEIN 
FIGURE 1 : Subcellular distribution of CAMP-binding activity. 
Spheroplasts from exponentially grown yeast cells were fractionated 
into plasma membrane (P), mitochondria (MIT), microsomes (M), 
and cytoplasm. Each fraction was assayed for adenylate cyclase, citrate 
synthase, succinate:cytochrome c oxidoreductase, NADH:cytochrome 
c oxidoreductase, hexokinase, and cAMP binding. The sum of protein 
recovered in all four compartments together was taken as 100%. The 
relative specific activities measured in the homogenate were set at 
1. The specific activities in the homogenate were as follows: adenylate 
cyclase, 41.4 pmol mg-l mi&; citrate synthase, 16.5 nmol mg-l min-'; 
succinate:cytochrome c oxidoreductase, 34.1 nmol mg-' min-I; 
NADH:cytochrome c oxidoreductase, 2.4 nmol mg-l min-I; hexokinase, 
9.5 nmol mg-I mi&; CAMP-binding, 1.4 pmol mg-'. 
accounts for about 15% of the total cellular CAMP-binding 
capacity, was also significantly enriched (more than 2-fold) 
(Figure 1). The filter assay failed to demonstrate significant 
binding of cAMP to cytsolic proteins among which the R 
subunit of the soluble CAMP-dependent protein kinase A was 
to be expected. Similar observations have been ascribed earlier 
to the tight binding of the ligand and the low dissociation rate 
which makes this complex resistant to the removal of the ligand 
by extensive dialysis. 
The binding of [3H]cAMP to plasma membranes was 
completely competed for by excess unlabeled cAMP (Figure 
2A) (but not by other adenosine 3'- and 5'-phosphate deriv- 
atives, data not shown). The Scatchard plot analysis [ac- 
cording to Fersht (1985)l of the cAMP binding to plasma 
membranes (Figure 2B) is in agreement with the existence of 
A T  B 
o J I # n l - r +  - 
0 10-l~ IO-* 10-~ IO- IO-' o 0.4 0.8 1.2 14 
cAMP [MI BOUND CAMP(-) 
FIGURE 2: cAMP binding to plasma membranes. (A) Solubilized 
plasma membranes were incubated with 4 nM [3H]cAMP in the 
presence of increasing concentrations of unlabeled cAMP and filtered 
(see Materials and Methods). Unspecific binding in the presence of 
1 pM unlabeled cAMP was subtracted from total binding. The results 
represent the means of four independent experiments (different 
membrane preparations, triplicate measurements each) with standard 
deviations shown by thin lines. (B) Scatchard plot derived from the 
binding data of the titration with unlabeled CAMP. 
FIGURE 3: 
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10 11 12 13 14 15 16 17 18 
Photoaffinity labelinn of cells and subcellular membranes 
with 8-N3-[32P]~AMP. -Lysed (lanes 1-3) and intact yeast spheroplasts 
(lanes 10-12), intact (lanes 7-9) and solubilized (lanes 4-6) plasma 
membrane vesicles, and intact (lanes 16-1 8) and solubilized (lanes 
13-1 5) mitochondria were photoaffinity labeled with 8-N3-[32P]cAMP 
in the presence or absence of a 100-fold molar excess of unlabeled 
CAMP. After solubilization and centrifugation, half of each super- 
natant was digested with N-glycanase (Gly). TCA-precipitated and 
washed samples were analyzed by SDS-PAGE and autoradiography. 
Molecular masses, indicated at the left margin, were calculated from 
marker proteins run on the same gel. 
a single type of high-affinity binding site for cAMP as the 
ligand. The dissociation constant, derived from the slope of 
the plot, Kd = 5.9 f 0.7 nM, is about 1 order of magnitude 
higher than the one reported for the cytosolic R subunit from 
yeast (Hixson & Krebs, 1980; Johnson et al., 1987). The 
concentration of binding sites calculated from the intercept 
of the abscissa is 1.34 pmol/mg of plasma membrane protein. 
Plasma Membranes Contain a Distinct Glycosylated 
CAMP-Binding Protein. A single protein with an electro- 
phoretic mobility corresponding to 54 000 Da was photoaf- 
finity-labeled by 8-N3-[32P]cAMP in intact and solubilized 
plasma membrane vesicles (Figure 3, lanes 4 and 7), sphero- 
plasts (lane lo), and lysed cells (lane 1). In the presence of 
excess unlabeled cAMP no such band could be detected (lanes 
3,5 ,8 ,  and 1 l ) ,  whereas 5'-AMP, which was routinely present 
in the labeling mixture, had no effect. This photoaffinity- 
labeled protein was clearly distinct from the mitochondrial 
cAMP receptor (M, = 46 OOO, lanes 13-1 8). The simultaneous 
labeling of both CAMP-binding proteins was observed in os- 
motic lysates (lanes 1 and 3) whereas in intact spheroplasts 
(lane 10) only the protein from plasma membranes could be 
labeled. This argued that the plasma membrane provides an 
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in partitioning, as were also extractions with alkaline sodium 
carbonate and CAMP, indicating a tight anchorage in the 
membrane. This behavior was independent of whether the 
protein had been deglycosylated (filled bars) or not (hatched 
bars). When, on the other hand, plasma membranes were 
treated with GPI-specific phospholipases, a significant portion 
of the cAMP receptor could be released into the soluble 
fraction, provided the membranes had been pretreated with 
N-glycanase (upper panel). Likewise, comparable amounts 
of hydrophilic cAMP receptor were recovered from the 
aqueous phase when a membrane digest by PLD was parti- 
tioned (independent of the presence or absence of carbohydrate 
side chains in this case; lower panel). Thus, membrane release 
of the cAMP receptor requires the cleavage both of the co- 
valently attached lipid (rendering the protein hydrophilic) and 
of carbohydrate moieties (eliminating polar interactions be- 
tween the protein and membrane components). Interestingly, 
membrane release by exogenous phospholipases depended on 
the type and source of the enzyme. PLA2 released from the 
membrane (after deglycosylation) and converted into the 
hydrophilic form only a small portion of the affinity-labeled 
receptor. More effective were (G)PI-PLC's from B. cereus 
(Stieger et al., 1986) (up to 50% cleavage) and T .  brucei 
(Bulow & Overath, 1986) (up to 75% cleavage). In contrast, 
"classical" GPI anchors are cleaved by these enzymes nearly 
quantitatively [for a review see Low (1989)l. However, some 
GPI-anchored proteins exhibit restricted susceptibility to 
(G)PI-PL's [for a review see Ferguson and Williams (1988); 
Low, 19891. They were shown to carry substitutions at the 
inositol ring. The anchor of the cAMP receptor protein from 
yeast plasma membranes may be modified in a way that also 
impedes access of PLAz and (G)PI-PLC to their substrate 
sites. On the other hand, treatment with exogenous GPI-PLD 
from rabbit serum (Davitz et al., 1987, 1983) released the 
CAMP-binding protein from the membrane very efficiently. 
The gel electrophoretic patterns of photoaffinity-labeled 
CAMP-binding protein from plasma membranes with and 
without treatment by GPI-PLD are displayed in Figure 5. 
This figure exemplifies the results compiled in Figure 4 and 
documents that treatment with GPI-PLD did not visibly 
change the electrophoretic mobility of the cAMP receptor 
protein but completely abolished its amphiphilic character. 
This was demonstrated by segregation of the cAMP receptor 
into the aqueous phase in TX-114 partitioning (Figure 5 ,  
compare lanes 3 and 4 in panel a with the respective lanes in 
panel d), Cleavage by phospholipases, preferentially by 
GPI-PLD, confirms that the membrane anchorage of the 
CAMP-binding protein from the plasma membrane is effected 
through a covalently linked lipid-containing structure. The 
anchor is under present investigation, and the detailed analysis 
of the structure, which has the characteristics of a glycolipid, 
will be published elsewhere. Interestingly, removal of the 
phosphatidylinositol moiety was prerequisite but not sufficient 
for membrane release. Liberation from the membrane into 
the supernatant fraction was significantly enhanced by high 
salt and a-MMP (compare lanes 1 and 2 in panel d with lanes 
5 and 6 in panel e or lanes 9 and 10 in panel f). Both agents 
were inefficient in the absence of lipase (panels b and c, lanes 
5-12). These data strengthen the view that the protein is not 
kept in the membrane exclusively by the covalently attached 
glycolipid anchor but, in addition, by accessory interactions 
of the carbohydrate side chains with so far unidentified 
membrane structures (receptor complex). 
Figure 5 provided also further evidence for the extracellular 
location of the CAMP-binding protein. In intact spheroplasts 
IOU ' 
FIGURE 4: Membrane association of the plasma membrane CAMP- 
binding protein. 8-N3- [32P]cAMP-labeled, photoaffinity-labeled 
plasma membranes were incubated in the presence (filled bars) or 
absence of N-glycanase (open bars) in the absence of detergent as 
described under Materials and Methods. Aliquots were treated with 
1 M KCI at 4 OC (high salt) or 0.1 mM cAMP at 30 OC or 0.2 M 
sodium carbonate (Na2C0,) on ice or with PLAl (PLA2) or (G)- 
PI-PLC from B. cereus (PLC, B.c.) or T. brucei (PLC, T.b.) or 
GPI-PLD from rabbit serum (PLD) or they were incubated without 
additions (control). Subsequently, half of each sample was subjected 
to TX-I 14 partitioning; the other half was centrifuged. The sum of 
the radioactivity in the aqueous and detergent phases, as well as in 
the supernatant and pellet fractions, respectively, was set at 100% 
in each experiment (pellet fractions and TX-114 phases are not shown). 
Results are the means of five independent experiments with standard 
deviations shown as thin bars. 
effective accessibility barrier for cAMP to the inner com- 
partments [see also Matsumoto et al. (1982b)l but not to the 
plasma membrane cAMP receptor and suggested that the 
CAMP-binding domain of the plasma membrane receptor is 
oriented toward the extracellular space. 
It is noteworthy that treatment of solubilized spheroplasts 
or plasma membranes with N-glycanase reduced the molecular 
weight of the photoaffinity-labeled plasma membrane 
CAMP-binding protein to approximately 44 000-46 000 (lanes 
3,6,9, and 12), providing evidence for its glycoprotein nature. 
The deglycosylated product (corresponding to the faster 
moving of the two bands) nearly comigrated with its mito- 
chondrial counterpart in SDS-PAGE (lanes 3 and 12), which 
latter remained unaffected by this treatment (lanes 15 and 18). 
The CAMP Receptor Is Anchored to the Plasma Membrane 
by Lipid and Carbohydrate. In mitochondria a CAMP-binding 
protein has been found recently to be anchored in the inner 
membrane through a lipid structure containing phosphati- 
dylinositol (Muller & Bandlow, 1989a). Lipid-modified 
proteins have also been described in the plasma membrane 
from yeast (Conzelmann et al., 1988, 1990; Vai et al., 1990). 
To test the possibility that the cAMP receptor is anchored to 
the plasma membrane via such a phosphatidylinositol moiety 
we examined the sensitivity of membrane association to 
(G)PI-PL's. Release from the membrane and conversion of 
the amphiphilic to a hydrophilic soluble form were monitored 
by examining both its release into the soluble supernatant 
[Figure 4, upper panel; pellet (not shown) and supernatant 
together represent loo%] and its recovery from the aqueous 
phase in TX-114 partitioning [Figure 4, lower panel; aqueous 
and TX-114 (not shown) phases together are set as loo%]. 
The figure shows that the uncleaved, membrane-anchored 
version of the CAMP-binding protein (control) could be re- 
covered almost quantitatively from the membranous pellet in 
the one and from the hydrophobic detergent phase in the other 
experiment. High salt was completely ineffective in extracting 
the protein into the soluble supernatant or the aqueous phase 
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FIGURE 5: Release from the cell surface of the plasma membrane 
cAMP receptor. A total of 125 pg of spheroplasts (spheropl.) or cells 
was photoaffinity labeled and incubated in the presence or absence 
(control) of GPI-PLD from rabbit serum (PLD) and then adjusted 
to 1 M KCI (high salt) or 10 mM a-MMP, whereas the control 
received buffer only. After 30 min, half of each sample was subjected 
to TX- 1 14 partitioning, the other half was centrifuged. The TCA- 
precipitated and acetone/ethanol-washed detergent (d) and aqueous 
phases (a) from partitioning and pellet (p) and supernatant (s) fractions 
from the centrifugation, respectively, were analyzed by SDS-PAGE 
and autoradiography. 
(panels d, e, and f; lanes 4,8, and 12), but not in whole cells 
(panels g, h, and i; lanes 4,8, and I2), not even in the presence 
of high salt and a-MMP (panels h and i; lanes 6 and IO), 
GPI-PLD had access to the lipidic anchor structure from the 
outside. Thus, the CAMP-binding protein is presumably lo- 
cated at the periplasmic side of the plasma membrane. 
Topological Studies on the CAMP-Binding Protein from 
Plasma Membranes. GPI-anchored plasma membrane pro- 
teins characterized from higher eukaryotic cells so far have 
been found to be located exclusively at the extracellular face 
of the plasma membrane [for a review see Low (1987); Cross, 
19901. In order to extend these studies to yeast we undertook 
a detailed study on the topology of the cAMP receptor from 
yeast plasma membranes. For this purpose we prepared 
plasma membrane vesicles in both membrane orientations. 
The efficiency of the separation of inside out and outside out 
vesicles by concanavalin A affinity chromatography (see 
Materials and Methods) was controlled by testing the ac- 
cessibility to proteolytic digestion of proteins with known 
membrane topology, e.g., adenylate cyclase, which is associated 
with the inner face of plasma membranes (Mitts et al., 1990). 
In the experiment shown in Figure 6A the two vesicle popu- 
lations were digested separately with increasing concentrations 
of trypsin and, after termination of the incubation, assayed 
for adenylate cyclase activity. Figure 6A shows that trypsin 
inactivated adenylate cyclase from detergent-solubilized ves- 
icles (X) and from vesicles sonicated in the presence of trypsin 
(0) with similar kinetics, showing that adenylate cyclase has 
comparable intrinsic protease sensitivities in both types of 
vesicles. By contrast, without further treatment (O), adenylate 
cyclase from outside out vesicles was about 6 times more 
resistant to the protease than that from the inverted ones. This 
inactivation behavior agrees well with the predicted sidedness 
of the plasma membrane vesicles after separation by conca- 
navalin A-Sepharose affinity chromatography. 
For determining the topological orientation of the cAMP 
receptor protein, similarly prepared inside out and outside out 
vesicles, photoaffinity labeled during sonication, were incubated 
with either serum GPI-PLD or nitrous acid [which is known 
to cleave GPI anchors at the characteristic non-acetylated 
glucosamine residue; see Ferguson and Cross ( 1984); Ferguson 
et al., 19851. The distribution of the labeled CAMP-binding 
protein between a supernatant and a pellet fraction obtained 
after centrifugation and between a detergent and an aqueous 
phase after TX- 1 14 partitioning was analyzed by SDS-PAGE 
and autoradiography. As shown in Figure 6B, GPI-PLD 
converted the CAMP-binding protein from outside out vesicles 
from the membrane-bound amphiphilic form (Figure 6B, lanes 
1 and 2) to a soluble hydrophilic form (lanes 3 and 4). By 
contrast, treatment of inside out vesicles with GPI-PLD 
(Figure 6C) had no effect on the location and amphiphilicity 
of the protein (Figure 6C, lanes 3 and 4). Also, nitrous acid 
significantly increased the portion of both the soluble and the 
hydrophilic form in outside out vesicles in a concentration- 
dependent manner (Figure 6B, lanes 5 and 7, and 6 and 8, 
respectively). After treatment of inside out vesicles with 
nitrous acid, the major fraction of the receptor protein re- 
mained associated with the inverted vesicle fraction (lanes 5 
and 7). However, in this case the protein was recovered from 
the aqueous phase after hydrophobic/hydrophilic partitioning 
(Figure 6C, lanes 6 and 8). Since nitrous acid is membrane 
permeable, it cleaves the glycolipid anchor in either orientation, 
leaving the cAMP receptor trapped in the lumen only of inside 
out vesicles. This experiment presents strong evidence that 
the head group of the anchor's lipid structure is inserted into 
the outer leaflet of the lipid bilayer of the plasma membrane, 
the core protein facing the extracellular space. 
The identical conclusion can be drawn from experiments, 
where the accessibility to N-glycanase was assayed. The 
above-found orientation of the cAMP receptor protein implies 
that the carbohydrate moiety(ies) of its N-glycosidic side 
chain(s) protrude into the extracellular space. This prediction 
was tested . P hotoa ffi n i t y- la beled cA M P- bind i ng protein in 
spheroplasts and inside out or outside out plasma membrane 
vesicles and solubilized plasma membranes was digested with 
N-glycanase, and the accessibility of the carbohydrate side 
chains was analyzed by SDS-PAGE and autoradiography. 
N-Glycanase treatment of outside out vesicles, solubilized 
membranes, and spheroplasts decreased the electrophoretic 
mobility of the photolabeled product from a position corre- 
sponding to 54 kDa to two species of 47 and 44 kDa (Figure 
6D, lanes 4, 6 and 8; the reason for the heterogeneity is not 
known, but it may be related to incomplete digestion). The 
molecular integrity of the receptors was preserved in inside 
out vesicles (lane 2). By contrast, in the control where inside 
out vesicles had been sonicated together with N-glycanase and 
then incubated, the same reduction in apparent molecular 
weight was observed as in spheroplasts and outside out vesicles 
(not shown). Thus, the N-glycosidic carbohydrate chain(s) 
of the plasma membrane cAMP receptor can be removed only 
when the enzyme has access to the extracellular face of the 
membrane. 
Genetic Relationship of the Plasma Membrane CAMP 
Receptor to the R Subunit of Cytoplasmic Protein Kinase A. 
The R subunit of PKA has been reported to occur associated 
with various membranes including plasma membranes in yeast 
(Behrens & Mazon, 1988). In each case where topological 
studies had been performed it was found that it was bound 
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FIGURE 6: (Panel A) Sidedness of plasma membrane vesicles. Plasma membrane vesicles (inside out and outside out) were incubated with 
various concentrations of trypsin (pretreated with TLCK) in the presence (X) or absence (0) of 1% TX-100 or during mild ultrasonic treatment 
(0). After the addition of a stop solution containing a 4-fold molar excess of soy bean trypsin inhibitor, 200 pM PMSF, and 1% BSA, the 
vesicles were centrifuged through a 1-mL cushion of 0.5 M sucrose. The vesicle pellet was washed, dissolved with 1% TX-100, and centrifuged. 
The supernatant was assayed for adenylate cyclase activity (n = 4). The specific activity, measured in control incubations of the two vesicle 
populations (absence of trypsin) was taken as 100%. Only minor differences were found when this control incubation was carried out in the 
absence or presence of detergent or sonication. (Panels B and C) Topological orientation of the membrane anchor. Plasma membrane vesicles 
were photoaffinity labeled with 8-N3-[32P]cAMP during ultrasonic oscillation (see Materials and iviethods). Reisolated vesicles were separated 
into outside out (B) and inside out vesicles (C) and subsequently subjected to GPI-PLD treatment (PLD) or nitrous acid deamination for 0.5 
h (N 0.5) or 1 h (N 1). or a control incubation (cont.) was carried out (60 min, 37 "C).  Half of each sample was centrifuged through a 0.5-mL 
cushion of 0.5 M sucrose. The pellet (P) was dissolved in sample buffer. The supernatant fraction (S), withdrawn from the top of the sucrose 
layer, was precipitated with 5% TCA and dissolved in sample buffer. The other half of the samples was subjected to TX-114 partitioning. 
Both, the detergent (D) and aqueous (A) phases, were precipitated with TCA and dissolved in sample buffer. All samples were analyzed by 
SDS-PAGE and autoradiography. (Panel D) Topological orientation of the carbohydrate moiety. Yeast spheroplasts were photoafinity labeled 
with 8-N3-[32P]cAMP. From one aliquot, plasma membranes were prepared and separated into inside out (in/out) and outside out (out/out) 
vesicles or solubilized with detergent (solub.); the other aliquot was left. Plasma membrane preparations and spheroplasts (spheropl.) were 
incubated in the presence or absence of N-glycanase (Gly). TCA-precipitated pellets were solubilized with sample buffer and analyzed by 
SDS-PAGE and autoradiography. Molecular masses shown on the right margin were derived from metabolically labeled (described elsewhere) 
and affinity-purified mitochondrial (46 kDa), plasma membrane (54 kDa), and deglycosylated plasma membrane (44 kDa) CAMP-binding 
proteins, run in  parallel on the same gel. 
to the cytoplasmic face of the respective membrane. In all 
these locations the complex was released from the membrane 
and the active kinase was dissociated from the inactive complex 
by the presence of cAMP (Nairn et al., 1985). The association 
with the membrane of the complex was suggested to be due 
to protein-protein interactions (Bregman et al., 1989). Al- 
though the anchorage by a lipid structure and the location at 
the periplasmic face of the plasma membrane argue that the 
cAMP receptor of the plasma membrane constitutes a novel 
type of CAMP-binding protein and is independent of the cy- 
toplasmic R subunit, the most compelling evidence for the 
nonidentity of the two proteins comes from genetic experi- 
ments. Mutant strain EG273-5A, deleted for BCY 1, the locus 
encoding the R subunit of the cytoplasmic protein kinase A 
(Cannon & Tatchell, 1987; Toda et al., 1987), was analyzed 
for the presence of a cAMP receptor protein in plasma mem- 
branes. As expected, a signal was absent from the cytoplasmic 
fractions from the bcy2, mutant strain, irrespective of whether 
the labeling was carried out with intact spheroplasts or with 
the isolated cytoplasmic fraction (Figure 7, lanes 1 and 5,  
respectively). Lane 4 shows the authentic affinity-labeled 
product from wild-type plasma membranes for comparison 
(ma). A similar signal (although at a position indicating a 
slightly lower electrophoretic mobility) was observed in plasma 
membranes from bcy2 mutant cells. It could be detected in 
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FIGURE 7: Photoaffinity labeling of a bcyl disruption mutant lacking 
the R subunit of PKA. Subcellular fractions (labeling fractions), total 
homogenate (labeling hom.), and spheroplasts (labeling spheropl.) 
were photoaffinity labeled with 8-N3-[32P]~AMP. Spheroplasts were 
subsequently fractionated into cytoplasm (CY), mitochondria (MT), 
and plasma membranes (PM). Half of the plasma membrane fraction 
and half of the homogenate were deglycosylated with N-glycanase 
(deglycos.), whereas the other fractions remained untreated. All 
samples were separated by SDS-PAGE and autoradiographed. 
Photoaffinity-labeled plasma membranes of the wild-type yeast strain 
were run in a parallel lane for comparison (ma). Molecular masses 
shown on the right margin were derived from marker proteins run 
on the same gel. 
8-N3-[32P]cAMP-labeled, isolated plasma membranes, and 
homogenate (lanes 3, 7, and 9). The portion of photoaffini- 
ty-labeled cAMP receptor associated with plasma membranes 
was significantly lower (lanes 3 and 7) than the total amount 
recovered in the homogenate (lane 9), suggesting that in the 
mutant the receptor (or a precursor) is retained in some in- 
tracellular compartment, presumably the ER or Golgi. The 
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higher apparent molecular mass of the CAMP-binding protein 
attributed to this signal (57 kDa compared to 54 kDa of the 
plasma membrane wild-type cAMP receptor) may be due to 
strain-specific differences or an altered or lacking (presumably 
C-terminal) proteolytic processing in the mutant strain. The 
apparent molecular mass could, however, be reduced to 46 kDa 
by treatment with N-glycanase (lanes 8 and lo), arguing that 
N-glycosylation occurs in a similar fashion to that in the wild 
type. In addition, a signal corresponding to a M, of 46 000 
was found in the mitochondrial fraction and in the homogenate 
of the mutant strain disrupted for BCYI, proving the presence 
of the mitochondrial isoprotein (lanes 6 and 9). This protein 
was unchanged in comparison with the wild-type situation 
(compare with Figure 3).  It nearly comigrated with the de- 
glycosylated plasma membrane cAMP receptor in the pho- 
toaffinity-labeled homogenate (lane 10). The data prove that 
the CAMP-binding proteins from plasma membranes and 
mitochondria are genetically unrelated to the cytoplasmic R 
subunit encoded by the BCYl gene. 
DISCUSSION 
Like all eukaryotes, the yeast S. cereuisiae contains a 
CAMP-dependent protein kinase in the cytoplasm. A single 
gene [called SRAl  by Cannon and Tatchell(l987) or REG1 
by Kunisawa et al. (1987) or BCYl by Toda et al. (1987)] 
encodes its R subunit. Recently, an additional CAMP-binding 
R subunit of a CAMP-dependent protein kinase has been 
discovered in yeast mitochondria (Rode1 et al., 1985; Muller 
& Bandlow, 1987). It is bound to the outer surface of the inner 
membrane by an anchor containing phosphatidylinositol 
(Muller & Bandlow, 1989a*), a covalent modification typical 
for certain plasma membrane (g1yco)proteins in higher and 
lower eukaryotes. GPI-anchored proteins have, indeed, been 
detected in yeast plasma membranes (Conzelmann et al., 1988, 
1990; Vai et al., 1990). In the course of the analysis of 
CAMP-dependent effects not mediated by the cytoplasmic 
PKA and recalling an earlier report on the presence of a 
CAMP-binding protein(s) in yeast plasma membranes (Jaynes 
et al., 1980), we examined cAMP binding to plasma mem- 
branes and describe here the identification of a phosphati- 
dylinositol-modified CAMP-binding protein. 
Genetic evidence excludes that the plasma membrane cAMP 
receptor is derived from the same gene (BCY1) as the R 
subunit of yeast cytoplasmic PKA. In addition, several lines 
of evidence strongly suggest that this protein also physically 
differs from the mitochondrial species. First, extensive 
cross-contamination of our plasma membrane preparations by 
mitochondria can be excluded. Our plasmalemma preparation 
is significantly deprived of both soluble and membrane-bound 
mitochondrial marker enzymes and concomitantly enriched 
in adenylate cyclase activity. Second, the size of the two 
membrane-associated CAMP-binding proteins differs markedly 
[plasma membrane 54 kDa, mitochondria 46 kDa; the soluble 
cytosolic CAMP-binding R subunit of yeast protein kinase A 
has a molecular mass of 51 kDa for comparison (Hixson & 
Krebs, 1980; Wingender-Drissen, 1983)]. Third, only the 
plasma membrane cAMP receptor is extensively N- 
glycosylated, which is consistent with its periplasmic orien- 
tation, whereas mitochondria lack a glycosyltransferase system. 
Fourth, although both proteins are anchored in the membrane 
by a covalently attached lipid structure containing glyceryl- 
phosphoinositol, only the anchor of the plasma membrane 
protein contains non-acetylated glucosamine (evident from the 
destruction by nitrous acid and from metabolic labeling studies 
that will be published elsewhere). The detailed analysis of the 
two anchors and the study of the relationship of their core 
Muller and Bandlow 
proteins will be subjects of future efforts. 
The lipid-modified plasma membrane cAMP reeptor is 
released from spheroplasts by exogenous GPI-PLD or by 
nitrous acid deamination in the presence of high salt without 
a noticeable shift in electrophoretic mobility in SDS-PAGE. 
On the other hand, it resists treatment of plasma membranes 
with high salt or alkaline sodium carbonate. Thus, membrane 
association of this protein is accomplished by its glycolipidic 
anchor and not by a proteinaceous transmembrane domain or 
by protein-protein interactions. The carbohydrate side chain 
appears to be involved in an additional salt-dissociable in- 
teraction with the membrane. After lipolytic cleavage of the 
membrane anchor, a-MMP (or high salt) facilitates, in a 
competitive fashion, the dissociation from the membrane. 
Removal of the side chain by N-glycanase exerts a similar 
effect. It may be speculated that these polar interactions 
between the carbohydrate side chain(s) of the cAMP receptor 
and the membrane keep the protein in contact either with a 
hypothetical anchor-degrading enzyme (phospholipase) or with 
a possible target. The prevention from dissociation from the 
cell surface is reminiscent of the situation with heparan sulfate 
proteoglycan in rat hepatocytes. This glycoprotein is bound 
to the plasma membrane through a phosphatidylinositol 
moiety. After cleavage of the membrane anchor by an intrinsic 
phospholipase C, the proteoglycan, with myo-inositol phosphate 
still attached to the core protein, remains membrane-associated 
via a cell surface receptor that recognizes the myo-inositol 
phosphate moiety and is subsequently internalized. Exogenous 
myo-inositol phosphate derivatives cause competitive dis- 
placement of the proteoglycan and exclusion from the cell 
matrix (Ishihara et al., 1987). 
It has been postulated that the binding of PKA to various 
intracellular membranes is mediated by bipolar interactions 
of the R subunit with integral membrane proteins (Sakar et 
al., 1984; Bregman et al., 1989; see Introduction). N-Terminal 
myristylation, demonstrated for the C subunit of PKA, may 
assist membrane attachment of the inactive complex (Carr et 
al., 1982; Kamps et al., 1985; Clegg et al., 1989). We have 
shown here that covalent modification by complete phospho- 
lipid structures provides an additional mode of membrane 
association of CAMP-binding proteins. cAMP has been ob- 
served to cause the release of an active C subunit from mem- 
brane-associated PKA’s (Nairn et al., 1985), whereas the 
second messenger has no effect on the protein described here. 
We present strong evidence that the CAMP-binding protein 
from yeast plasma membranes is oriented toward the extra- 
cellular space. First, right side out plasma membrane vesicles, 
characterized by their binding to concanavalin A-Sepharose 
via their externally exposed mannoproteins, lose the CAMP- 
binding protein upon treatment with GPI-PLD or upon nitrous 
acid deamination by contrast to inverted vesicles. Second, 
GPI-PLD liberates the CAMP-binding protein from sealed 
spheroplasts. Third, N-glycanase has access to the N- 
glycosidic side chain(s) of the receptor in spheroplasts and 
outside out plasma membrane vesicles but not in inside out 
vesicles. Fourth, the membrane-impermeable 8-N3-cAMP 
labels the plasma membrane cAMP receptor in intact 
spheroplasts. This deduced topology is in agreement with the 
current view of the biogenesis of both carbohydrate- and 
GPI-modified membrane proteins. Both N-glycosylation and 
replacement of a transient proteinaceous transmembrane do- 
main by a glycolipid in a pseudotranspeptidation reaction are 
thought to occur in the endoplasmic reticulum (Takami et al., 
1988; Caras et al., 1989; Caras & Weddell, 1989; Doering et 
al., 1990). After their passage through the secretory pathway 
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these proteins have an outward orientation. 
It is interesting to note in this context that recently evidence 
for the extracellular Occurrence of a CAMP-dependent protein 
kinase was found in HeLa, Chinese hamster ovary, and mouse 
lymphoma S49 cells (Kiibler et al., 1989). As in the case of 
the yeast plasma membrane cAMP receptor, the constituent 
CAMP-binding protein of this kinase was not released by 
cAMP alone. Surprisingly, it was also observed that throm- 
bin-stimulated rabbit platelets release a protein kinase that 
specifically phosphorylates a plasma protein in a CAMP-de- 
pendent manner (Korc-Grodzicki et al., 1988). Unfortunately, 
the mode of membrane anchorage has not been determined 
in these cases. 
The extracellular location of the CAMP-binding protein 
facing the periplasmic space raises the question of the avail- 
ability of cAMP at the cell surface. Extracellular cAMP most 
likely originates from the secretion of cytoplasmic cAMP into 
the cell exterior rather than from the conversion of extra- 
cellular ATP involving enzymes at the cell surface (Trams, 
1974; Wen et al., 1985). Recently, extrusion of cAMP from 
intact mammalian cells with the characteristics of an active 
transport was reported (Brunton & Heasley, 1988). In ad- 
dition, Smith et al. (1990) demonstrated the extrusion of 
cAMP from yeast cells into the medium, the extracellular 
levels being 10-100 times higher than the intracellular pool. 
Interestingly, the extracellular level of cAMP does not fluc- 
tuate during the cell cycle, making a role of the lipid-modified 
CAMP-binding protein of the plasma membrane in the regu- 
lation of the cell cycle unlikely. 
With the exception of the extracellular cAMP receptor from 
Dictyostelium discoideum all CAMP-binding proteins in eu- 
karyotic cells are assumed to function as regulatory subunits 
of CAMP-dependent protein kinases [for a review see Lohmann 
and Walter ( 1  984)]. CAMP-dependent protein phosphoryla- 
tion was believed to be mediated exclusively through the cy- 
toplasmic PKA and its isoforms (Corbin et al., 1977; Flockart 
& Corbin, 1982; Lohmann et al., 1984; DeCamilli et al., 1986). 
Although the C subunit of the CAMP-dependent protein kinase 
in mitochondria, which phosphorylates a 40-kDa inner mem- 
brane protein in a CAMP-dependent manner, has not yet been 
physically identified, the corresponding CAMP-binding protein 
represents the first example of a phosphatidylinositol-anchored 
R subunit of a CAMP-dependent protein kinase (Muller & 
Bandlow, 1987). But protein phosphorylation occurs only after 
the lipolytic release of the RC complex from the membrane 
(Muller & Bandlow, 1989~).  Thus, lipid modification seems 
to provide a novel mode for membrane association and regu- 
lation of CAMP-dependent protein kinases, epistatic over the 
modulation by CAMP. The extracellular orientation of the 
cAMP receptor, in addition, implies the reconsideration of the 
exclusive role of cAMP as an intracellular second messenger 
in yyast (and perhaps in other cells). It remains to be es- 
tablished whether the GPI-anchored CAMP-binding ecto- 
protein of the plasma membrane belongs to the same type of 
protein kinase as the mitochondrial isoprotein. 
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